Rubella revisited: where are we on the road to disease elimination in Central Europe?
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F11%3A10106434" target="_blank" >RIV/00179906:_____/11:10106434 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/60162694:G44__/11:00002603
Výsledek na webu
<a href="http://www.sciencedirect.com/science/article/pii/S0264410X11015465" target="_blank" >http://www.sciencedirect.com/science/article/pii/S0264410X11015465</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.vaccine.2011.09.104" target="_blank" >10.1016/j.vaccine.2011.09.104</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Rubella revisited: where are we on the road to disease elimination in Central Europe?
Popis výsledku v původním jazyce
Rubella is a contagious viral disease with few complications except when contracted by pregnant women. Rubella infection in pregnancy can result in miscarriage, stillbirth or an infant born with congenital rubella syndrome (CRS) which comprises deafness,heart disease, cataracts and other permanent congenital manifestations. Clinical diagnosis of rubella is difficult due to overlapping symptoms with many other diseases and confirmation of rubella is not possible without laboratory testing.Effective vaccination programmes are critical to the elimination of rubella and prevention of CRS. Such programmes have been successful in several countries in Europe and around the world. However, rubella outbreaks still occur due to suboptimal vaccine coverage and in the past 10 years rubella has been reported in Central European countries such as Romania and Poland. Over the past decade the elimination of rubella and prevention of congenital rubella infection in Europe has been a high priority for
Název v anglickém jazyce
Rubella revisited: where are we on the road to disease elimination in Central Europe?
Popis výsledku anglicky
Rubella is a contagious viral disease with few complications except when contracted by pregnant women. Rubella infection in pregnancy can result in miscarriage, stillbirth or an infant born with congenital rubella syndrome (CRS) which comprises deafness,heart disease, cataracts and other permanent congenital manifestations. Clinical diagnosis of rubella is difficult due to overlapping symptoms with many other diseases and confirmation of rubella is not possible without laboratory testing.Effective vaccination programmes are critical to the elimination of rubella and prevention of CRS. Such programmes have been successful in several countries in Europe and around the world. However, rubella outbreaks still occur due to suboptimal vaccine coverage and in the past 10 years rubella has been reported in Central European countries such as Romania and Poland. Over the past decade the elimination of rubella and prevention of congenital rubella infection in Europe has been a high priority for
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FN - Epidemiologie, infekční nemoci a klinická imunologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Ostatní
Rok uplatnění
2011
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Vaccine
ISSN
0264-410X
e-ISSN
—
Svazek periodika
29
Číslo periodika v rámci svazku
49
Stát vydavatele periodika
NL - Nizozemsko
Počet stran výsledku
7
Strana od-do
9141-9147
Kód UT WoS článku
000297525500005
EID výsledku v databázi Scopus
—